To say there's a growing demand for specialty pharmacy is anunderstatement of vast proportions.

Today, some 57 million working-age Americans with chronicillnesses are able to stay on the job due to advances inbiotechnology and the development of specialty pharmaceuticals. Theeffectiveness of these drugs, combined with demand from patients,has pushed drug companies to develop additional new drugs forchronic, debilitating illnesses.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.